Placebo effects in primary insomnia

Michael L. Perlis, W. Vaughn McCall, Carla R. Jungquist, Wilfred R. Pigeon, Sara E. Matteson

Research output: Contribution to journalShort survey

38 Citations (Scopus)

Abstract

Placebo effects are commonly observed in insomnia clinical trials. With the advent of longer-term trials, such effects appear to be remarkably robust and durable. In this paper we review the classic factors that are believed to contribute to placebo effects and how these factors operate in insomnia randomized clinical trials. Beyond this we suggest that the episodic nature of insomnia may interact with patient preferences for intermittent dosing in such a way as to sustain placebo effects in the long term. An appreciation of the latter phenomenon may provide increased power to detect therapeutic outcomes and may be used to potentiate clinical gains.

Original languageEnglish (US)
Pages (from-to)381-389
Number of pages9
JournalSleep Medicine Reviews
Volume9
Issue number5
DOIs
StatePublished - Oct 2005

Fingerprint

Placebo Effect
Sleep Initiation and Maintenance Disorders
Patient Preference
Randomized Controlled Trials
Clinical Trials
Therapeutics

Keywords

  • Insomnia
  • Periodicity of insomnia
  • Placebo effects
  • Randomized clinical trials

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Perlis, M. L., McCall, W. V., Jungquist, C. R., Pigeon, W. R., & Matteson, S. E. (2005). Placebo effects in primary insomnia. Sleep Medicine Reviews, 9(5), 381-389. https://doi.org/10.1016/j.smrv.2005.05.001

Placebo effects in primary insomnia. / Perlis, Michael L.; McCall, W. Vaughn; Jungquist, Carla R.; Pigeon, Wilfred R.; Matteson, Sara E.

In: Sleep Medicine Reviews, Vol. 9, No. 5, 10.2005, p. 381-389.

Research output: Contribution to journalShort survey

Perlis, ML, McCall, WV, Jungquist, CR, Pigeon, WR & Matteson, SE 2005, 'Placebo effects in primary insomnia', Sleep Medicine Reviews, vol. 9, no. 5, pp. 381-389. https://doi.org/10.1016/j.smrv.2005.05.001
Perlis ML, McCall WV, Jungquist CR, Pigeon WR, Matteson SE. Placebo effects in primary insomnia. Sleep Medicine Reviews. 2005 Oct;9(5):381-389. https://doi.org/10.1016/j.smrv.2005.05.001
Perlis, Michael L. ; McCall, W. Vaughn ; Jungquist, Carla R. ; Pigeon, Wilfred R. ; Matteson, Sara E. / Placebo effects in primary insomnia. In: Sleep Medicine Reviews. 2005 ; Vol. 9, No. 5. pp. 381-389.
@article{c6b08b565fdc47c199b6d6d57e1334bd,
title = "Placebo effects in primary insomnia",
abstract = "Placebo effects are commonly observed in insomnia clinical trials. With the advent of longer-term trials, such effects appear to be remarkably robust and durable. In this paper we review the classic factors that are believed to contribute to placebo effects and how these factors operate in insomnia randomized clinical trials. Beyond this we suggest that the episodic nature of insomnia may interact with patient preferences for intermittent dosing in such a way as to sustain placebo effects in the long term. An appreciation of the latter phenomenon may provide increased power to detect therapeutic outcomes and may be used to potentiate clinical gains.",
keywords = "Insomnia, Periodicity of insomnia, Placebo effects, Randomized clinical trials",
author = "Perlis, {Michael L.} and McCall, {W. Vaughn} and Jungquist, {Carla R.} and Pigeon, {Wilfred R.} and Matteson, {Sara E.}",
year = "2005",
month = "10",
doi = "10.1016/j.smrv.2005.05.001",
language = "English (US)",
volume = "9",
pages = "381--389",
journal = "Sleep Medicine Reviews",
issn = "1087-0792",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Placebo effects in primary insomnia

AU - Perlis, Michael L.

AU - McCall, W. Vaughn

AU - Jungquist, Carla R.

AU - Pigeon, Wilfred R.

AU - Matteson, Sara E.

PY - 2005/10

Y1 - 2005/10

N2 - Placebo effects are commonly observed in insomnia clinical trials. With the advent of longer-term trials, such effects appear to be remarkably robust and durable. In this paper we review the classic factors that are believed to contribute to placebo effects and how these factors operate in insomnia randomized clinical trials. Beyond this we suggest that the episodic nature of insomnia may interact with patient preferences for intermittent dosing in such a way as to sustain placebo effects in the long term. An appreciation of the latter phenomenon may provide increased power to detect therapeutic outcomes and may be used to potentiate clinical gains.

AB - Placebo effects are commonly observed in insomnia clinical trials. With the advent of longer-term trials, such effects appear to be remarkably robust and durable. In this paper we review the classic factors that are believed to contribute to placebo effects and how these factors operate in insomnia randomized clinical trials. Beyond this we suggest that the episodic nature of insomnia may interact with patient preferences for intermittent dosing in such a way as to sustain placebo effects in the long term. An appreciation of the latter phenomenon may provide increased power to detect therapeutic outcomes and may be used to potentiate clinical gains.

KW - Insomnia

KW - Periodicity of insomnia

KW - Placebo effects

KW - Randomized clinical trials

UR - http://www.scopus.com/inward/record.url?scp=24144445384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144445384&partnerID=8YFLogxK

U2 - 10.1016/j.smrv.2005.05.001

DO - 10.1016/j.smrv.2005.05.001

M3 - Short survey

C2 - 16109495

AN - SCOPUS:24144445384

VL - 9

SP - 381

EP - 389

JO - Sleep Medicine Reviews

JF - Sleep Medicine Reviews

SN - 1087-0792

IS - 5

ER -